Skip to content

Tirzepatide studies: 457 papers with results

Page 9 of 10

  1. Glucagon-Like Peptide-1 Receptor Agonists Versus Bariatric Surgery in Patients With Obesity and Heart Failure With Preserved Ejection Fraction.

    Ibrahim R · Journal of the American Heart Association · 2025

    Not a test of Tirzepatide alone · 14 results

  2. Cancer risk of glucagon-like peptide-1 receptor agonists for obesity: comparison with bariatric surgery and other weight-loss drugs.

    Bitar ER · Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2026

    Not a test of Tirzepatide alone · 14 results

  3. Characterization of Interchanging Incretin Analogs in Clinical Practice: A Descriptive Report.

    Hvisdas CM · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025

    Not a test of Tirzepatide alone · 14 results

  4. Evaluating the Rates of Pancreatitis and Pancreatic Cancer Among GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

    Wen J · Endocrinology, diabetes & metabolism · 2025

    Not a test of Tirzepatide alone · 18 results

  5. GLP-1RA versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: An updated meta-analysis of randomized controlled trials.

    Duhan S · International journal of cardiology · 2025

    Not a test of Tirzepatide alone · 12 results

  6. Impact of GLP-1 Analogue Therapy on Gastrointestinal Outcomes in Patients with Irritable Bowel Syndrome: A Real-World TriNetX Analysis.

    Khan SA · Digestive diseases and sciences · 2026

    Not a test of Tirzepatide alone · 24 results

  7. Glucagon-like peptide-1 agonists in children with obesity and type 2 diabetes. an umbrella review.

    Mirghani H · Frontiers in endocrinology · 2026

    Not a test of Tirzepatide alone · 18 results

  8. GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis.

    Beaudart C · Drugs · 2026

    Not a test of Tirzepatide alone · 20 results

  9. Basal insulin intensification with GLP-1RA and dual GIP and GLP-1RA in patients with uncontrolled type 2 diabetes mellitus: A rapid review of randomized controlled trials and meta-analysis.

    Lisco G · Frontiers in endocrinology · 2022

    Not a test of Tirzepatide alone · 5 results

  10. Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial.

    Pratley RE · Nature medicine · 2026

    Not a test of Tirzepatide alone · 5 results

  11. A Systematic Review Identifying Critical Evidence Gaps in Reporting Dietary Change in Randomized Controlled Trials Prescribing Liraglutide, Semaglutide, or Tirzepatide.

    Jansson AK · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026

    Not a test of Tirzepatide alone · 15 results

  12. Expectations and Outcomes From Glucagon-Like Peptide-1 Receptor Agonists As Adjunct Treatment for Type 1 Diabetes - Case Presentations.

    Seetharaman S · Journal of diabetes science and technology · 2025

    Not a test of Tirzepatide alone · 10 results

  13. Real-World Alcohol Use Disorder Outcomes in Patients With Concurrent Metabolic Dysfunction: GLP-1 Receptor Agonists Versus FDA-Approved AUD Medications.

    Gougol A · Alimentary pharmacology & therapeutics · 2026

    Not a test of Tirzepatide alone · 10 results

  14. Systemic Pharmacokinetic Principles of Therapeutic Peptides.

    Nordell P · Clinical pharmacokinetics · 2026

    Not a test of Tirzepatide alone · 22 results

  15. Computational modelling the impact of GLP-1 receptor agonists on botulinum toxin A: Evidence for reduced treatment durability across neurologic and aesthetic indications.

    Rahman E · Toxicon : official journal of the International Society on Toxinology · 2026

    Not a test of Tirzepatide alone · 20 results

  16. Real-world prescribing patterns and early weight and blood pressure outcomes of GLP-1-based therapies: a retrospective observational study in the United Arab Emirates.

    Almemari S · BMC endocrine disorders · 2026

    Not a test of Tirzepatide alone · 5 results

  17. GLP-1-based therapies and limb outcomes in PAD: a systematic review and meta-analysis of real-world studies.

    Boccatonda A · Diabetes research and clinical practice · 2026

    Not a test of Tirzepatide alone · 5 results

  18. Impact of GLP-1 receptor agonists on cardiovascular outcomes in heart failure with preserved ejection fraction (HFpEF): systematic review and meta-analysis.

    Gonzales-Uribe A · Clinical research in cardiology : official journal of the German Cardiac Society · 2026

    Not a test of Tirzepatide alone · 8 results

  19. Newer Glucagon-Like Peptide-1 Receptor Agonists Are Associated With Improved Glycemic Control in US Adults With Type 2 Diabetes: A Population-Level Time Series Analysis.

    Lv L · Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2025

    Not a test of Tirzepatide alone · 12 results

  20. Case Report: Amelioration of severe metabolic dysfunction-associated steatohepatitis after switching from conventional GLP-1RAs to tirzepatide.

    Oe Y · Frontiers in endocrinology · 2025

    Not a test of Tirzepatide alone · 7 results

  21. Clinical Outcomes Associated with GLP-1 Receptor Agonist Exposure in Non-Diabetic Patients with Chronic Pancreatitis: A Retrospective Cohort Study.

    Dhali A · Journal of personalized medicine · 2026

    Not a test of Tirzepatide alone · 12 results

  22. Glucagon-Like Peptide-1 receptor agonists, dual GIP/GLP-1 receptor agonist tirzepatide and suicidal ideation and behavior: A systematic review of clinical studies and pharmacovigilance reports.

    Di Stefano R · Diabetes & metabolic syndrome · 2025

    Not a test of Tirzepatide alone · 3 results

  23. Beyond Weight Loss: Comparative Effects of Tirzepatide Plus Low-Energy Ketogenic Versus Low-Calorie Diet on Hepatic Steatosis and Stiffness in MASLD.

    Schiavo L · Nutrients · 2025

    Not a test of Tirzepatide alone · 3 results

  24. Preservation of lean soft tissue during weight loss induced by GLP-1 and GLP-1/GIP receptor agonists: A case series.

    Tinsley GM · SAGE open medical case reports · 2025

    Not a test of Tirzepatide alone · 6 results

  25. Efficacy and Safety of GLP-1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA.

    Sinha B · Obesity (Silver Spring, Md.) · 2025

    Not a test of Tirzepatide alone · 12 results

  26. Efficacy of incretin-based therapies in obesity-related obstructive sleep apnea: a systematic review and meta-analysis of randomized controlled trials.

    Bardóczi A · Sleep medicine reviews · 2025

    Not a test of Tirzepatide alone · 6 results

  27. Efficacy and Safety of GLP- 1 Receptor Agonists in the Management of Weight Recurrence or Suboptimal Clinical Response after Undergoing Metabolic Bariatric Surgeries: A Meta-Analysis.

    Arrowaili A · Obesity surgery · 2025

    Not a test of Tirzepatide alone · 11 results

  28. Sleeve-to-bypass conversion vs. sleeve-with-adjuvant GLP-1 receptor agonists: an academic multicenter retrospective study.

    Brown A · Surgical endoscopy · 2025

    Not a test of Tirzepatide alone · 6 results

  29. Single and Combined Impact of Semaglutide, Tirzepatide, and Metformin on β-Cell Maintenance and Function Under High-Glucose-High-Lipid Conditions: A Comparative Study.

    Gojani EG · International journal of molecular sciences · 2025

    Not a test of Tirzepatide alone · 6 results

  30. First report on a case series of Patulous Eustachian tube following GLP-1 receptor agonist-induced weight loss.

    Sudhoff H · European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025

    Not a test of Tirzepatide alone · 6 results

  31. GLP-1 RA Medication Associations With Hazardous Alcohol Drinking Reductions in Patients With Overweight or Obesity: A Prospective Observational Study.

    King AC · Journal of addiction medicine · 2026

    Not a test of Tirzepatide alone · 9 results

  32. Roux-en-Y Gastric Bypass Compared to Glucagon-Like Peptide-1 Receptor Agonists is Associated with Lower Out-of-Pocket Costs in Insured Patients with Type 2 Diabetes and Obesity: A Matched Analysis Over Two Years.

    Thiyagarajan S · Obesity surgery · 2026

    Not a test of Tirzepatide alone · 6 results

  33. Pharmacist-led management of GLP-1 and GIP/GLP-1 receptor agonists in type 2 diabetes mellitus.

    Park MJ · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2026

    Not a test of Tirzepatide alone · 12 results

  34. Comparative effectiveness of continuous positive airway pressure and glucagon-like peptide-1 receptor agonists in obstructive sleep apnea: A network meta-analysis of randomised trials.

    Chiappa GR · Diabetes, obesity & metabolism · 2026

    Not a test of Tirzepatide alone · 9 results

  35. GLP-1 Receptor Agonists and Dual GIP/GLP-1 Receptor Agonists in Children and Adolescents with Obesity: Clinical Outcomes and the Impact of Nutritional and Behavioral Co-Interventions-A Systematic Review.

    Myśliwczyk D · Nutrients · 2026

    Not a test of Tirzepatide alone · 10 results

  36. Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists.

    Barrett TS · JAMA surgery · 2025

    Not a test of Tirzepatide alone · 9 results

  37. Fusion Outcomes of GLP-1 Agonist Therapy in Multilevel Cervical Spinal Fusion: A Propensity-Matched Analysis.

    Vatsia SK · Clinical spine surgery · 2025

    Not a test of Tirzepatide alone · 8 results

  38. GLP-1RAs and tirzepatide may reduce heart failure risk in obese but not in non-obese patients with cardiovascular or renal disease: A systematic review and meta-analysis.

    Zhang J · Metabolism: clinical and experimental · 2026

    Not a test of Tirzepatide alone · 2 results

  39. Weight Loss, Obesity Medication, and Risk of Obesity-Associated Cancer: A Meta-Analysis of Randomized Controlled Trials.

    Li C · Obesity (Silver Spring, Md.) · 2026

    Not a test of Tirzepatide alone · 2 results

  40. Bariatric surgery vs. GLP-1 receptor agonists among primarily medicare and medicaid patients with diabetes: a 3-year analysis.

    Brown A · Surgical endoscopy · 2026

    Not a test of Tirzepatide alone · 4 results

  41. TikTok's take on adverse effects for glucagon-like peptide-1 and gastric inhibitory polypeptide receptor agonists.

    Wantuch GA · Journal of the American Pharmacists Association : JAPhA · 2025

    Not a test of Tirzepatide alone · 4 results

  42. Investigating GLP-1 Injections: Potential Mitochondrial Dysfunction in Non-Diabetic Patients Presenting with Migraines and Hypoglycemia: A Case Report.

    Jamail J · Integrative medicine (Encinitas, Calif.) · 2024

    Not a test of Tirzepatide alone · 4 results

  43. Hypertensive disorders of pregnancy and GLP-1 receptor agonist timing: a systematic review and meta-analysis.

    Pisani D · Endocrine · 2026

    Not a test of Tirzepatide alone · 6 results

  44. Development and validation of a multiplexed LC-HRMS method for nine GLP-1 receptor agonists and its pharmaceutical application.

    Tong LH · Journal of chromatography. A · 2026

    Not a test of Tirzepatide alone · 13 results

  45. Postmarketing Safety Signals and Medication-Use Risks of GLP-1-Based Therapies in Diabetes and Obesity: A Multi-Source Pharmacovigilance and Regulatory Evidence-Mapping Study.

    Ren L · Diabetes, obesity & metabolism · 2026

    Not a test of Tirzepatide alone · 8 results

  46. Discontinuing glucagon-like peptide-1 receptor agonists and body habitus: A systematic review and meta-analysis.

    Berg S · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025

    Not a test of Tirzepatide alone · 5 results

  47. Sex, race, and BMI in clinical trials of medications for obesity over the past three decades: a systematic review.

    Alsaqaaby MS · The lancet. Diabetes & endocrinology · 2024

    Not a test of Tirzepatide alone · 6 results

  48. Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes.

    Buse JB · Diabetes care · 2025

    Not a test of Tirzepatide alone · 1 result

  49. Compounded glucagon-like peptide-1 receptor agonists for weight loss: the direct-to-consumer market in Colorado.

    DiStefano MJ · Journal of pharmaceutical policy and practice · 2025

    Not a test of Tirzepatide alone · 5 results

  50. Gastrointestinal Adverse Effects of Anti-Obesity Medications in Non-Diabetic Adults: A Systematic Review.

    Takrori E · Medicina (Kaunas, Lithuania) · 2025

    Not a test of Tirzepatide alone · 4 results

How PepBank reports evidence